Melinda Sanders

Title: Melinda Sanders - Innovator in Cancer Immunotherapy

Introduction

Melinda Sanders is a prominent inventor based in Nashville, TN, who has made significant contributions to the field of cancer treatment. She holds a patent that focuses on methods and systems for predicting responses to immunotherapies, which is crucial for advancing cancer care.

Latest Patents

Melinda Sanders holds a patent titled "Methods and systems for predicting response to immunotherapies for treatment of cancer." This patent describes a method for detecting cell membrane expression of an MHC molecule in a subject. It outlines a process for treating cancer using an immunotherapeutic agent, which involves obtaining a tumor cell sample and detecting the expression of the MHC molecule through specific antibody binding. The patent also details how to administer a therapeutically effective amount of the immunotherapeutic agent based on the detected levels of MHC expression.

Career Highlights

Melinda Sanders is affiliated with Vanderbilt University, where she contributes to research and innovation in cancer therapies. Her work is instrumental in developing new approaches to immunotherapy, which can significantly improve patient outcomes.

Collaborations

Some of her notable coworkers include Justin M Balko and Douglas B Johnson, who collaborate with her on various research projects aimed at enhancing cancer treatment methodologies.

Conclusion

Melinda Sanders is a key figure in the field of cancer immunotherapy, with her innovative patent paving the way for more effective treatment options. Her contributions to research at Vanderbilt University highlight her commitment to improving cancer care through scientific advancements.